BMS-986446 receives FDA fast track designation for alzheimer's treatment
Go back to BMS-986446 receives FDA fast track designation for alzheimer's treatment| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 67.01 +1.54 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.47 | 52 Week High | $77.12 | |||
| Open | $65.79 | 52 Week Low | $49.03 | |||
| Day High | $67.55 | P/E | 43.51 | |||
| Day Low | $65.13 | EPS | $1.54 | |||
| Volume | 7,932,248 | |||||
| PROTHENA CORP (NASDAQ: PRTA) | Delayed: 9.45 +0.42 (4.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.03 | 52 Week High | $76.42 | |||
| Open | $9.11 | 52 Week Low | $28.20 | |||
| Day High | $9.52 | P/E | N/A | |||
| Day Low | $9.09 | EPS | $-2.84 | |||
| Volume | 376,045 | |||||
